Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 131

1.

Long-term, prolonged-release tacrolimus-based immunosuppression in de novo kidney transplant recipients: 5-year prospective follow-up of the ADHERE study patients.

Rummo O, Carmellini M, Kamar N, Durrbach A, Mousson C, Caputo F, Mathe Z, Christiaans MHL, Rj Kuypers D, Klempnauer J, Anaokar S, Hurst M, Kazeem G, Undre N, Lehner F.

Transpl Int. 2019 Sep 19. doi: 10.1111/tri.13527. [Epub ahead of print]

PMID:
31536654
2.

Endothelial dysfunction and low-grade inflammation in the transition to renal replacement therapy.

Gennip ACEV, Broers NJH, Meulen KJT, Canaud B, Christiaans MHL, Cornelis T, Gelens MACJ, Hermans MMH, Konings CJAM, Net JBV, Sande FMV, Schalkwijk CG, Stifft F, Wirtz JJJM, Kooman JP, Martens RJH.

PLoS One. 2019 Sep 13;14(9):e0222547. doi: 10.1371/journal.pone.0222547. eCollection 2019.

3.

Relations of advanced glycation endproducts and dicarbonyls with endothelial dysfunction and low-grade inflammation in individuals with end-stage renal disease in the transition to renal replacement therapy: A cross-sectional observational study.

Martens RJH, Broers NJH, Canaud B, Christiaans MHL, Cornelis T, Gauly A, Hermans MMH, Konings CJAM, van der Sande FM, Scheijen JLJM, Stifft F, Wirtz JJJM, Kooman JP, Schalkwijk CG.

PLoS One. 2019 Aug 13;14(8):e0221058. doi: 10.1371/journal.pone.0221058. eCollection 2019.

4.

Antibodies against ARHGDIB are associated with long-term kidney graft loss.

Kamburova EG, Gruijters ML, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Melchers RCA, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Bemelman FJ, Otten HG.

Am J Transplant. 2019 Jun 13. doi: 10.1111/ajt.15493. [Epub ahead of print]

PMID:
31194283
5.

Equivalent Long-term Transplantation Outcomes for Kidneys Donated After Brain Death and Cardiac Death: Conclusions From a Nationwide Evaluation.

Schaapherder A, Wijermars LGM, de Vries DK, de Vries APJ, Bemelman FJ, van de Wetering J, van Zuilen AD, Christiaans MHL, Hilbrands LH, Baas MC, Nurmohamed AS, Berger SP, Alwayn IP, Bastiaannet E, Lindeman JHN.

EClinicalMedicine. 2018 Oct 9;4-5:25-31. doi: 10.1016/j.eclinm.2018.09.007. eCollection 2018 Oct-Nov.

6.

Allocation to highly sensitized patients based on acceptable mismatches results in low rejection rates comparable to nonsensitized patients.

Heidt S, Haasnoot GW, Witvliet MD, van der Linden-van Oevelen MJH, Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Otten HG, Roelen DL, Claas FHJ.

Am J Transplant. 2019 Oct;19(10):2926-2933. doi: 10.1111/ajt.15486. Epub 2019 Jul 1.

PMID:
31155833
7.

Living-donor transplantation leads to a major improvement in physical functioning: an observational study on the impact on potential donors and their recipients.

Broers NJH, Fung TY, Kooman JP, Christiaans MHL.

BMC Nephrol. 2019 Mar 29;20(1):109. doi: 10.1186/s12882-019-1299-9.

8.

Development and Validation of a Multiplex Non-HLA Antibody Assay for the Screening of Kidney Transplant Recipients.

Kamburova EG, Kardol-Hoefnagel T, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Meeldijk J, Bovenschen N, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Front Immunol. 2018 Dec 19;9:3002. doi: 10.3389/fimmu.2018.03002. eCollection 2018.

9.

Effect of initial immunosuppression on long-term kidney transplant outcome in immunological low-risk patients.

Michielsen LA, van Zuilen AD, Verhaar MC, Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Hilbrands LB.

Nephrol Dial Transplant. 2018 Dec 15. doi: 10.1093/ndt/gfy377. [Epub ahead of print]

PMID:
30561730
10.

Erratum.

Kers J, Peters-Sengers H, Heemskerk MBA, Berger SP, Betjes MGH, van Zuilen AD, Hilbrands LB, de Fijter JW, Nurmohamed AS, Christiaans MH, Homan van der Heide JJ, Debray TPA, Bemelman FJ.

Nephrol Dial Transplant. 2018 Oct 29. doi: 10.1093/ndt/gfy353. [Epub ahead of print] No abstract available.

PMID:
30376111
11.

A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival.

Michielsen LA, Wisse BW, Kamburova EG, Verhaar MC, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JF, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, van Zuilen AD.

Nephrol Dial Transplant. 2019 Jun 1;34(6):1056-1063. doi: 10.1093/ndt/gfy316.

PMID:
30365008
12.

The prevalence of antibodies against the HLA-DRB3 protein in kidney transplantation and the correlation with HLA expression.

Habets THPM, Hepkema BG, Kouprie N, Schnijderberg MCA, van Smaalen TC, Bungener LB, Christiaans MHL, Bos GMJ, Vanderlocht J.

PLoS One. 2018 Sep 7;13(9):e0203381. doi: 10.1371/journal.pone.0203381. eCollection 2018.

13.

Toward a Sensible Single-antigen Bead Cutoff Based on Kidney Graft Survival.

Wisse BW, Kamburova EG, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Stephan Sanders J, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Transplantation. 2019 Apr;103(4):789-797. doi: 10.1097/TP.0000000000002357.

14.

Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens MACJ, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KAMI, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma AJ, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

J Am Soc Nephrol. 2018 Sep;29(9):2279-2285. doi: 10.1681/ASN.2018020205. Epub 2018 Jul 26.

15.

Increase in tacrolimus exposure after steroid tapering is influenced by CYP3A5 and pregnane X receptor genetic polymorphisms in renal transplant recipients.

Stifft F, van Kuijk SMJ, Bekers O, Christiaans MHL.

Nephrol Dial Transplant. 2018 Sep 1;33(9):1668-1675. doi: 10.1093/ndt/gfy096.

PMID:
29733390
16.

PIRCHE-II Is Related to Graft Failure after Kidney Transplantation.

Geneugelijk K, Niemann M, Drylewicz J, van Zuilen AD, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Hack CE, van Reekum FE, Verhaar MC, Kamburova EG, Bots ML, Seelen MAJ, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MGJ, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed A, Lardy JNM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG, Spierings E.

Front Immunol. 2018 Mar 5;9:321. doi: 10.3389/fimmu.2018.00321. eCollection 2018.

17.

Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant.

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar MC, Bots ML, Drop ACAD, Plaisier L, Seelen MAJ, Sanders JSF, Hepkema BG, Lambeck AJA, Bungener LB, Roozendaal C, Tilanus MGJ, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MHL, van Ittersum FJ, Nurmohamed SA, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJM, Bemelman FJ, Hoitsma A, van der Boog PJM, de Fijter JW, Betjes MGH, Heidt S, Roelen DL, Claas FH, Otten HG.

Am J Transplant. 2018 Sep;18(9):2274-2284. doi: 10.1111/ajt.14709. Epub 2018 Apr 16.

18.

Predicition models for delayed graft function: external validation on The Dutch Prospective Renal Transplantation Registry.

Kers J, Peters-Sengers H, Heemskerk MBA, Berger SP, Betjes MGH, van Zuilen AD, Hilbrands LB, de Fijter JW, Nurmohamed AS, Christiaans MH, Homan van der Heide JJ, Debray TPA, Bemelman FJ.

Nephrol Dial Transplant. 2018 Jul 1;33(7):1259-1268. doi: 10.1093/ndt/gfy019.

PMID:
29462353
19.

The development of D antibodies after D-mismatched kidney transplantation in a setting of reduced immunosuppression.

Habets THPM, Vanderlocht J, Straat RJMHE, van Smaalen TC, Bos GMJ, Beckers EA, Christiaans MHL, Henskens YMC.

Transfusion. 2018 Jan;58(1):100-104. doi: 10.1111/trf.14405. Epub 2017 Nov 29.

PMID:
29193117
20.

Routine haemostasis testing before transplanted kidney biopsy: a cohort study.

Kuiper GJAJM, Christiaans MHL, Mullens MHJM, Ten Cate H, Hamulýak K, Henskens YMC.

Transpl Int. 2018 Mar;31(3):302-312. doi: 10.1111/tri.13090. Epub 2017 Nov 21.

21.

No evidence for progressive deterioration in stimulated insulin secretion in renal transplant recipients after 12years tacrolimus exposure.

Gelens MACJ, van Hooff JP, Usvyat L, Christiaans MH.

J Diabetes Complications. 2017 Sep;31(9):1384-1388. doi: 10.1016/j.jdiacomp.2017.07.001. Epub 2017 Jul 4.

PMID:
28720321
22.

Presence of Cytotoxic Extracellular Histones in Machine Perfusate of Donation After Circulatory Death Kidneys.

van Smaalen TC, Beurskens DM, Hoogland ER, Winkens B, Christiaans MH, Reutelingsperger CP, van Heurn LW, Nicolaes GA.

Transplantation. 2017 Apr;101(4):e93-e101. doi: 10.1097/TP.0000000000001590.

PMID:
27906828
23.

ADHERE: randomized controlled trial comparing renal function in de novo kidney transplant recipients receiving prolonged-release tacrolimus plus mycophenolate mofetil or sirolimus.

Rummo OO, Carmellini M, Rostaing L, Oberbauer R, Christiaans MH, Mousson C, Langer RM, Citterio F, Charpentier B, Brown M, Kazeem G, Lehner F; ADHERE study investigators.

Transpl Int. 2017 Jan;30(1):83-95. doi: 10.1111/tri.12878. Epub 2016 Nov 28.

24.

Stretching the Limits of Renal Transplantation in Elderly Recipients of Grafts from Elderly Deceased Donors.

Peters-Sengers H, Berger SP, Heemskerk MB, Al Arashi D, Homan van der Heide JJ, Hemke AC, Ten Berge IJ, Idu MM, Betjes MG, van Zuilen AD, Hilbrands LB, de Vries AP, Nurmohamed AS, Christiaans MH, Ernest van Heurn LW, de Fijter JW, Bemelman FJ.

J Am Soc Nephrol. 2017 Feb;28(2):621-631. doi: 10.1681/ASN.2015080879. Epub 2016 Oct 11.

25.

Increased risk of graft failure and mortality in Dutch recipients receiving an expanded criteria donor kidney transplant.

van Ittersum FJ, Hemke AC, Dekker FW, Hilbrands LB, Christiaans MH, Roodnat JI, Hoitsma AJ, van Diepen M.

Transpl Int. 2017 Jan;30(1):14-28. doi: 10.1111/tri.12863.

26.

Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies: ADVANCE, A Randomized Controlled Trial.

Mourad G, Glyda M, Albano L, Viklický O, Merville P, Tydén G, Mourad M, Lõhmus A, Witzke O, Christiaans MHL, Brown MW, Undre N, Kazeem G, Kuypers DRJ; Advagraf-based immunosuppression regimen examining new onset diabetes mellitus in kidney transplant recipients (ADVANCE) study investigators.

Transplantation. 2017 Aug;101(8):1924-1934. doi: 10.1097/TP.0000000000001453.

27.

How can we reduce costs of solid-phase multiplex-bead assays used to determine anti-HLA antibodies?

Kamburova EG, Wisse BW, Joosten I, Allebes WA, van der Meer A, Hilbrands LB, Baas MC, Spierings E, Hack CE, van Reekum FE, van Zuilen AD, Verhaar M, Bots ML, Drop AC, Plaisier L, Seelen MA, Sanders JS, Hepkema BG, Lambeck AJ, Bungener LB, Roozendaal C, Tilanus MG, Vanderlocht J, Voorter CE, Wieten L, van Duijnhoven EM, Gelens M, Christiaans MH, van Ittersum FJ, Nurmohamed A, Lardy NM, Swelsen W, van der Pant KA, van der Weerd NC, Ten Berge IJ, Bemelman FJ, Hoitsma A, van der Boog PJ, de Fijter JW, Betjes MG, Heidt S, Roelen DL, Claas FH, Otten HG.

HLA. 2016 Sep;88(3):110-9. doi: 10.1111/tan.12860. Epub 2016 Aug 18.

PMID:
27534609
28.

Granulomatous interstitial nephritis and Crohn's disease.

Timmermans SA, Christiaans MH, Abdul-Hamid MA, Stifft F, Damoiseaux JG, van Paassen P.

Clin Kidney J. 2016 Aug;9(4):556-9. doi: 10.1093/ckj/sfw041. Epub 2016 May 26.

29.

Similar 5-Year Estimated Glomerular Filtration Rate Between Kidney Transplants From Uncontrolled and Controlled Donors After Circulatory Death-A Dutch Cohort Study.

Peters-Sengers H, Homan van der Heide JJ, Heemskerk MBA, Ten Berge IJM, Ultee FCW, Idu MM, Betjes MGH, van Zuilen AD, Christiaans MHL, Hilbrands LH, de Vries APJ, Nurmohamed AS, Berger SP, Bemelman FJ.

Transplantation. 2017 Jun;101(6):1144-1151. doi: 10.1097/TP.0000000000001211.

30.

Effect of Breakfast on the Exposure of the Once-Daily Tacrolimus Formulation in Stable Kidney Transplant Recipients.

Stifft F, Undre N, van Hooff JP, Christiaans MH.

Ther Drug Monit. 2016 Aug;38(4):456-62. doi: 10.1097/FTD.0000000000000311.

PMID:
27128604
31.

Towards a standardised informed consent procedure for live donor nephrectomy: the PRINCE (Process of Informed Consent Evaluation) project-study protocol for a nationwide prospective cohort study.

Kortram K, Spoon EQ, Ismail SY, d'Ancona FC, Christiaans MH, van Heurn LW, Hofker HS, Hoksbergen AW, Homan van der Heide JJ, Idu MM, Looman CW, Nurmohamed SA, Ringers J, Toorop RJ, van de Wetering J, Ijzermans JN, Dor FJ.

BMJ Open. 2016 Apr 1;6(4):e010594. doi: 10.1136/bmjopen-2015-010594.

32.

The Dutch Transplantation in Vasculitis (DUTRAVAS) Study: Outcome of Renal Transplantation in Antineutrophil Cytoplasmic Antibody-associated Glomerulonephritis.

Göçeroğlu A, Rahmattulla C, Berden AE, Reinders ME, Wolterbeek R, Steenbergen EJ, Hilbrands LB, Noorlander I, Berger SP, Peutz-Kootstra CJ, Christiaans MH, van Dijk MC, de Joode AA, Goldschmeding R, van Zuilen AD, Harper L, Little MA, Hagen EC, Bruijn JA, Bajema IM.

Transplantation. 2016 Apr;100(4):916-24. doi: 10.1097/TP.0000000000000910.

PMID:
26371598
33.

Cervicovaginal HPV infection in female renal transplant recipients: an observational, self-sampling based, cohort study.

Meeuwis KA, Hilbrands LB, IntHout J, Slangen BF, Hendriks IM, Hinten F, Christiaans MH, Quint WG, van de Kerkhof PC, Massuger LF, Hoitsma AJ, van Rossum MM, Melchers WJ, de Hullu JA.

Am J Transplant. 2015 Mar;15(3):723-33. doi: 10.1111/ajt.13053. Epub 2015 Feb 12.

34.

The Maastricht Transplant Center: clinical setting and epitope searches in HLA class II molecules: does the structural localization of a polymorphic site contribute to its immunogenicity?

Schellekens J, Vanderlocht J, Groeneweg M, Voorter CE, Wieten L, Gelens MA, van Duijnhoven EM, van Heurn LW, Christiaans MH, Tilanus MG.

Transpl Immunol. 2014 Oct;31(4):213-8. doi: 10.1016/j.trim.2014.09.002. Epub 2014 Sep 21. Review.

PMID:
25240735
35.

The pharmacokinetics of everolimus in de novo kidney transplant patients receiving tacrolimus: an analysis from the randomized ASSET study.

Rostaing L, Christiaans MH, Kovarik JM, Pascual J.

Ann Transplant. 2014 Jul 14;19:337-45. doi: 10.12659/AOT.890673.

36.

Lower variability in 24-hour exposure during once-daily compared to twice-daily tacrolimus formulation in kidney transplantation.

Stifft F, Stolk LM, Undre N, van Hooff JP, Christiaans MH.

Transplantation. 2014 Apr 15;97(7):775-80. doi: 10.1097/01.TP.0000437561.31212.0e.

PMID:
24686426
37.

Improvements in kidney transplantation from donors after cardiac death.

Hoogland ER, Snoeijs MG, Habets MA, Brandsma DS, Peutz-Kootstra CJ, Christiaans MH, van Heurn LW.

Clin Transplant. 2013 May-Jun;27(3):E295-301. doi: 10.1111/ctr.12107. Epub 2013 Mar 7.

PMID:
23464536
38.

Kidneys from uncontrolled donors after cardiac death: which kidneys do worse?

Pieter Hoogland ER, van Smaalen TC, Christiaans MH, van Heurn LW.

Transpl Int. 2013 May;26(5):477-84. doi: 10.1111/tri.12067. Epub 2013 Feb 6.

39.

The value of machine perfusion biomarker concentration in DCD kidney transplantations.

Hoogland ER, de Vries EE, Christiaans MH, Winkens B, Snoeijs MG, van Heurn LW.

Transplantation. 2013 Feb 27;95(4):603-10. doi: 10.1097/TP.0b013e31827908e6.

PMID:
23296150
40.

Immunosuppressive regimen and interstitial fibrosis and tubules atrophy at 12 months postrenal transplant.

Gelens MA, Steegh FM, van Hooff JP, van Suylen RJ, Nieman FH, van Heurn LW, Peutz-Kootstra CJ, Christiaans MH.

Clin J Am Soc Nephrol. 2012 Jun;7(6):1010-7. doi: 10.2215/CJN.09030911. Epub 2012 Apr 5.

41.

Preservation of kidneys from controlled donors after cardiac death.

Wind J, Snoeijs MG, van der Vliet JA, Winkens B, Christiaans MH, Hoitsma AJ, van Heurn LW.

Br J Surg. 2011 Sep;98(9):1260-6. doi: 10.1002/bjs.7543. Epub 2011 Jun 8.

PMID:
21656512
42.

Early loss of peritubular capillaries after kidney transplantation.

Steegh FM, Gelens MA, Nieman FH, van Hooff JP, Cleutjens JP, van Suylen RJ, Daemen MJ, van Heurn EL, Christiaans MH, Peutz-Kootstra CJ.

J Am Soc Nephrol. 2011 Jun;22(6):1024-9. doi: 10.1681/ASN.2010050531. Epub 2011 May 12.

43.

Tubular epithelial injury and inflammation after ischemia and reperfusion in human kidney transplantation.

Snoeijs MG, van Bijnen A, Swennen E, Haenen GR, Roberts LJ 2nd, Christiaans MH, Peppelenbosch AG, Buurman WA, Ernest van Heurn LW.

Ann Surg. 2011 Mar;253(3):598-604. doi: 10.1097/SLA.0b013e31820d9ae9.

PMID:
21248631
44.

Kidney transplantation from donors after cardiac death: a 25-year experience.

Snoeijs MG, Winkens B, Heemskerk MB, Hoitsma AJ, Christiaans MH, Buurman WA, van Heurn LW.

Transplantation. 2010 Nov 27;90(10):1106-12. doi: 10.1097/TP.0b013e3181f83b0b.

PMID:
20861804
45.

Acute ischemic injury to the renal microvasculature in human kidney transplantation.

Snoeijs MG, Vink H, Voesten N, Christiaans MH, Daemen JW, Peppelenbosch AG, Tordoir JH, Peutz-Kootstra CJ, Buurman WA, Schurink GW, van Heurn LW.

Am J Physiol Renal Physiol. 2010 Nov;299(5):F1134-40. doi: 10.1152/ajprenal.00158.2010. Epub 2010 Sep 1.

46.

Kidneys from donors after cardiac death provide survival benefit.

Snoeijs MG, Schaubel DE, Hené R, Hoitsma AJ, Idu MM, Ijzermans JN, Ploeg RJ, Ringers J, Christiaans MH, Buurman WA, van Heurn LW.

J Am Soc Nephrol. 2010 Jun;21(6):1015-21. doi: 10.1681/ASN.2009121203. Epub 2010 May 20.

47.

Outcome of carotid artery stenting for radiation-induced stenosis.

Dorresteijn LD, Vogels OJ, de Leeuw FE, Vos JA, Christiaans MH, Ackerstaff RG, Kappelle AC.

Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1386-90. doi: 10.1016/j.ijrobp.2009.06.045. Epub 2010 Jan 29.

PMID:
20116932
48.

HLA-DP antibodies before and after renal transplantation.

Billen EV, Christiaans MH, Doxiadis II, Voorter CE, van den Berg-Loonen EM.

Tissue Antigens. 2010 Mar;75(3):278-85. doi: 10.1111/j.1399-0039.2009.01428.x. Epub 2010 Jan 11.

PMID:
20070601
49.

Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.

Billen EV, Christiaans MH, van den Berg-Loonen EM.

Tissue Antigens. 2009 Sep;74(3):205-12. doi: 10.1111/j.1399-0039.2009.01283.x. Epub 2009 Jun 2.

PMID:
19497037
50.

Pre-kidney-transplant blood transfusions do not improve transplantation outcome: a Dutch national study.

Aalten J, Bemelman FJ, van den Berg-Loonen EM, Claas FH, Christiaans MH, de Fijter JW, Hepkema BG, Hené RJ, van der Heide JJ, van Hooff JP, Lardy NM, Lems SP, Otten HG, Weimar W, Allebes WA, Hoitsma AJ.

Nephrol Dial Transplant. 2009 Aug;24(8):2559-66. doi: 10.1093/ndt/gfp233. Epub 2009 May 27.

PMID:
19474284

Supplemental Content

Loading ...
Support Center